Predictions of the death of print have been around for while, but there’s nothing like walking into a really well-stocked newsagents to make you consider the medium anew.
As newspapers like the New York Times take a leaf out of the magazine playbook and indie-published titles flourish, it’s no wonder there are suggestions 2017 could mark another turning point in print’s fortunes. Read the rest of this entry »
It’s easy to over-estimate the ubiquity of the smartphone and its capabilities, not least in the UK where 81% of adults were last year estimated to have one.
But the global picture is one of much more variety and, according to a recent report, almost half of mobile phone users are happy to use their devices as, well, mobile telephones. Read the rest of this entry »
I’ve been learning Bengali off and on for over ten years now and am, unsurprisingly, always on the look-out for digital tools to help me with the language.
Despite it being the seventh most spoken language in the world, it’s not the easiest task, with on- and offline Bengali resources being few and far between.
So, although it’s probably years away from being available in my chosen language, I was nonetheless taken by the recent expansion of Google Translate’s Word Lens to Japanese. Read the rest of this entry »
In this month’s issue of PME magazine we balance the changes that are already the theme of 2017 with some much needed stability in the form of a look at family-owned or foundation-run pharmaceutical companies.
Such European businesses include Germany’s Boehringer Ingelheim, Italy’s Chiesi and Denmark’s LEO Pharma, whose president and CEO Gitte Aabo talked to us about playing the long game and how this sees it through times of boom and bust. Read the rest of this entry »
At almost 310 metres high The Shard is the tallest building in the capital, towering over its London neighbours in Southwark.
One of those in its shadow is the site for what will become Science Gallery London, an exhibition and performance space that, from 2018, hopes to connect scientific researchers, students, local communities and artists. Read the rest of this entry »
As PME‘s first issue of the year comes out the European pharmaceutical industry goes into 2017 steeling itself for the start of Brexit, with plenty of words already devoted to what we don’t know about the implications of the UK’s vote to leave the European Union.
This year should see the phony war end and hostilities begin in earnest when the UK formally triggers Article 50 and commences the official process of withdrawing from the EU. Read the rest of this entry »